Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients

Clinical trial NCT00919035 · COMPLETED

Trial details

NCT number: NCT00919035
Sponsor: Oncology Specialists, S.C.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2009-06-01
Primary completion: 2013-02-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.